Literature DB >> 11119402

Hormones to prevent coronary disease in women: when are observational studies adequate evidence?

D Grady, S B Hulley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11119402     DOI： 10.7326/0003-4819-133-12-200012190-00016

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study.

Authors:  A D Struthers; P T Donnan; P Lindsay; D McNaughton; J Broomhall; T M MacDonald
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 2.  Homocysteine and atherothrombosis.

Authors:  E Falk; J Zhou; J Møller
Journal:  Lipids       Date:  2001       Impact factor: 1.880

3.  Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.

Authors:  Robert S Weinstein; A Michael Parfitt; Robert Marcus; Maria Greenwald; Gerald Crans; Douglas B Muchmore
Journal:  Osteoporos Int       Date:  2003-08-28       Impact factor: 4.507

Review 4.  Blood pressure, arterial function, structure, and aging: the role of hormonal replacement therapy in postmenopausal women.

Authors:  Angelo Scuteri; Luigi Ferrucci
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738

5.  The paired availability design for historical controls.

Authors:  S G Baker; K S Lindeman; B S Kramer
Journal:  BMC Med Res Methodol       Date:  2001-09-26       Impact factor: 4.615
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.